Othera Files IND Application for OT-730 in Glaucoma
Novel Treatment Promises Improved Safety over Existing Therapies
04-Aug-2008 -
Othera Pharmaceuticals, Inc., announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for OT-730, an oculoselective beta-blocker, as a potential treatment for glaucoma. A Phase 1-2 safety and efficacy trial is planned for completion ...
clinical trials
food
glaucoma
+3